$AMN

Indian Health Service faces a 30% job vacancy rate, citing housing as a major barrier. BOXABL Inc. (BXBL) is building workforce housing for Sage Memorial Hospital in Arizona. AMN Healthcare (AMN) reports increased physician salaries and signing bonuses. Legacy Housing (LEGH), Target Hospitality (TH), and WillScot (WSC) also discuss workforce housing projects and financial performance.

BMO Capital upgraded AMN Healthcare Services to 'Outperform' and raised its price target to $43.00 from $40.00, citing confidence in the company's healthcare staffing market performance. GuruFocus values AMN at $29.53, indicating a 23.6% overvaluation. The stock has a GF Score of 63/100, reflecting moderate financial health. No recent insider trading activity was reported.

Bank of America raised its price target for AMN Healthcare Services from $26 to $28. The stock has seen a 5-day change of 34.92 USD, a 1st Jan change of +2.25%, and a 1-year change of +3.53%.

AMN Healthcare (AMN) reported Q2 revenue of $673.2M, up 2% YoY, with net income of $21.2M. Travel nurse and allied staffing revenue grew 10% and 8% YoY, respectively. However, Physician and Leadership Solutions revenue fell 6% and Technology and Workforce Solutions revenue dropped 15% YoY. The company expects these declines to continue in Q3.

BMO Capital maintained an Outperform rating for AMN Healthcare Services (AMN) and raised its price target to $40.00 from $38.00. AMN is currently trading at $33.05, which is 11.2% above its GF Value™ of $29.71, indicating overvaluation. The company has a GF Score™ of 63, reflecting moderate performance, with strengths in profitability and financial strength but weaknesses in growth. Insiders have sold $114,369 worth of shares in the past three months.

AMN Healthcare Services' stock has surged 118.7% year-to-date, outperforming its industry and the S&P 500. Q2 revenues rose 2.3% to $673M, exceeding guidance, with adjusted EPS up 158% YoY. Growth is driven by strong demand in nurse and allied staffing, technology enhancements, and persistent healthcare workforce shortages. The company's 2026 EPS is projected to grow 127.9% to $3.10, with revenues expected to rise 20.9% to $3.30B.

AMN Healthcare Services reported Q2 2026 sales of $673.24M and returned to profitability. The company also joined the AONL Foundation Corporate Advisory Council. Analysts debate whether earnings momentum and raised guidance will sustain revenue stability amid margin pressures and tighter hospital budgets. AMN projects $2.4B revenue and $2.5M earnings by 2029, but some analysts expect a 9% revenue decline annually.

AMN Healthcare reported Q2 2026 language services revenue of $69.6m, down 8% YoY due to pricing pressure. Overall revenue rose 2% to $673.2m, with net income at $21.2m. The company acquired Jaide Health for AI interpreting services and expects Q3 revenue of $640m-$655m.

A Q2 earnings wrap for 39 healthcare providers and services stocks says group revenues beat analysts’ consensus by 1.7% and next-quarter guidance was 1.6% above. It highlights AMN Healthcare Services (AMN) revenue of $673.2M (+2.3% YoY), beating estimates by 7.2%, and stock up 11.7% to $34.41. Other featured names include CVS, AdaptHealth, McKesson, and Encompass Health.

AMN Healthcare reported Q2 2026 revenue of $673 million, up 2% year over year and 6% above the top end of guidance, with adjusted EPS of $0.77. Adjusted EBITDA was $73 million (10.9% margin) after $27 million in nonrecurring billing true-ups. Q3 revenue guidance is $640 million to $655 million. AMN also authorized share repurchases and acquired Jaide Health and ESSENTIAL.